1. HBW Insight
  2. >>Leadership

Perrigo’s Next CEO Has Long OTC Brands History

Lockwood-Taylor Moves From Bayer As Perrigo Awaits Decision On OTC Oral Contraceptive

 
• By Malcolm Spicer

Patrick Lockwood-Taylor starts as president/CEO on 30 June, succeeding Murray Kessler as Perrigo awaits FDA decision on subsidiary HRA’s proposal for first US OTC sales of daily oral contraceptive. He’s moving from president of Bayer AG’s US business and regional president, consumer health North America.

• Source: Shutterstock

Perrigo Company PLC’s transition from leading the OTC drug private label/store brand space to also competing in branded consumer health product sales will be in the hands of an industry veteran with experience at two firms behind some of the most well-known global brands.

Perrigo firm on 8 June announced Patrick Lockwood-Taylor will start as president and CEO on 30 June, succeeding Murray Kessler...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

Over The Counter: Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper

 
• By David Ridley

HBW Insight speaks to Haleon's UK & Ireland general manager Jo Cooper about how she plans to translate the firm's ambitious global growth strategy to a local context.

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By David Ridley

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

Growing With Purpose – Inside Kenvue’s ‘Healthy Lives Mission’

 
• By David Ridley

HBW Insight speaks to Kenvue's global head of sustainability, Jennifer Duran, about the company's “Healthy Lives Mission,” including insights into how the firm is decarbonizing its supply chain, reducing the use of plastics and embedding sustainability into the design of new products.

From ‘Work Harder’ to ‘Phenomenal People’: Makary’s FDA About-Face

 
• By Michael McCaughan

In his first 100 days as FDA commissioner, Martin Makary has gone from vocal critic to vocal supporter of the agency’s staff, calling them “phenomenal” and praising their dedication—even as morale remains shaken by recent layoffs and restructuring.

More from HBW Insight

PCPC: US Sunscreen Regs, State Recycling Laws A Burden For Trade

 
• By Lauren Nardella

The Personal Care Products Council identifies sunscreen regulations among federal laws that place US industry at a competitive disadvantage, in comments to the Federal Trade Commission and the US Department of Justice Antitrust Division.

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’

 
• By Malcolm Spicer

PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.

Manufacturers Can Keep Their Shoes On: FDA PreCheck To Streamline US Facility Applications

 
• By Derrick Gingery

The program would allow early interactions with FDA staff to speed construction and approval of pharmaceutical manufacturing facilities in the US, but will staff be available?